Brainstorm Cell Therapeutics reported $-2.05M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Biogen USD 514.3M 502.8M Mar/2026
Brainstorm Cell Therapeutics USD -2.05M 526K Sep/2025
Cipla INR 6.14B 3.63B Mar/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Cytokinetics USD -181.23M 2.86M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
Mesoblast USD -27.75M 14.36M Dec/2025